Table 2. Annual mean SCR scores by radiotherapy.
SCR: standardized claim-data ratio; N.A.: Not applicable
| Radiotherapy | 2018, mean ± SD | 2019, mean ± SD | 2020, mean ± SD | 2021, mean ± SD |
| Lung cancer | 101.2±23.5 | 101.8±23.9 | 101.7±22.8 | 100.4±23.3 |
| Metastatic lung cancer | N.A. | N.A. | N.A. | 103.0±36.7 |
| Gastric cancer | 100.7±34.4 | 102.1±37.9 | 103.4±39.8 | 99.0±34.8 |
| Colorectal cancer | 100.9±26.0 | 100.8±27.6 | 99.5±28.2 | 102.3±28.2 |
| Hepatocellular carcinoma | 99.9±27.2 | 101.8±31.9 | 101.9±31.9 | 107.2±50.4 |
| Metastatic liver cancer | N.A. | N.A. | N.A. | 102.7±40.8 |
| Breast cancer | 107.1±53.1 | 105.7±58.0 | 107.2±28.1 | 103.3±50.0 |